De-Risking AI: Objective Audit Standards for Clinical Algorithms

The promise of artificial intelligence in healthcare hinges not just on its far-reaching potential, but on our collective ability to ensure its responsible deployment. While regulatory bodies increasingly champion transparency in clinical algorithms, a critical chasm persists between disclosure mandates and the establishment of objective, verifiable auditing standards. Bridging this gap is paramount for safeguarding patient safety, fostering trust, and unlocking the full value of AI in clinical settings.

The Imperative for Actionable Algorithmic Auditing

The current regulatory field, while evolving, often places the onus of understanding complex AI models primarily on developers and, to a lesser extent, on end-users. This approach, while a necessary first step, falls short of strong algorithmic accountability. Transparency, in its current form, frequently translates to documentation rather than active compliance verification. For regulatory policy draftsmen and federal health IT administrators, the challenge lies in crafting a framework that moves beyond passive disclosures to a system where clinical algorithms can be objectively audited, much like any other medical device or clinical process. The stakes are high, particularly as the ECRI AI healthcare hazard rankings for 2026 have been released and the AMA has intensified its focus on AI healthcare oversight in the same period, signaling a growing recognition of inherent risks.

Using ONC Transparency with NIST’s Risk Management Framework

The Office of the National Coordinator for Health Information Technology (ONC), under the leadership of Micky Tripathi, has made significant strides with its HTI-1 Transparency Requirements. These rules are foundational, pushing for greater insight into how AI/ML-enabled software functions within certified health IT. However, to translate these transparency requirements into a strong audit framework, collaboration with the National Institute of Standards and Technology (NIST) is essential. NIST’s AI Risk Management Framework (AI RMF) provides a complete, flexible, and voluntary framework designed to manage risks associated with AI. Its core functions, Govern, Map, Measure, and Manage, offer a structured approach that can be directly applied to clinical algorithms. The teamwork is clear:

• Govern: The ONC can mandate that developers articulate their AI governance policies in alignment with the AI RMF’s Govern function, requiring them to document how they plan for, oversee, and manage AI risks throughout the lifecycle.
• Map: Developers would be required to “map” their clinical algorithms against known risks and potential impacts, a process that could be standardized through ONC guidance, drawing directly from NIST’s recommendations for identifying and characterizing AI risks.
• Measure: This is where objective auditing truly takes shape. NIST’s framework emphasizes measuring AI system performance and impact. The ONC, in collaboration with NIST, can establish specific metrics and methodologies for how clinical algorithms must be measured for bias, fairness, accuracy, robustness, and explainability. This moves beyond self-attestation to verifiable data.
• Manage: The AI RMF’s Manage function focuses on mitigating and responding to identified risks. ONC regulations could require explicit risk management plans for clinical algorithms, including strategies for monitoring algorithmic drift, a critical concern for evolving AI models, and for addressing performance degradation post-deployment.

This integrated approach would transform ONC’s transparency mandates into a powerful mechanism for active compliance verification, ensuring that the information disclosed is not merely present but auditable against established standards.

A Step-by-Step Methodology for Federal Algorithmic Auditing

To transition from passive disclosure to active compliance verification, federal agencies can implement a phased, step-by-step methodology:

Phase 1: Standardized Disclosure and Attestation Templates

The first step involves developing standardized templates for AI developers to disclose information mandated by ONC HTI-1. These templates should be granular, requiring specific details on:

• Model Architecture and Training Data: Including details on data provenance, patient demographics, and data labeling processes.
• Performance Metrics: Requiring reporting on key performance indicators (e.g., sensitivity, specificity, PPV, NPV) across relevant demographic subgroups, aligning with NIST’s “Measure” function.
• Bias Mitigation Strategies: Documenting methods used to detect and mitigate bias during development and deployment.
• Change Management Protocols: Detailing how updates and retraining are handled, important for addressing algorithmic drift and aligning with concepts like a Predetermined Change Control Plan (PCCP) if applicable. FDA guidance on AI/ML-based SaMD modifications

These templates would serve as the initial audit trail, providing a consistent baseline for evaluation.

Phase 2: Development of Objective Audit Protocols

Building on the standardized disclosures, the ONC and NIST should jointly develop objective audit protocols. These protocols would specify:

• Data Requirements for Audits: Defining the type and volume of real-world data (RWE) needed to independently verify reported performance metrics.
• Testing Methodologies: Establishing approved statistical methods and simulation environments for assessing algorithmic fairness, robustness, and reliability. This could include adversarial testing and stress testing scenarios.
• Explainability Requirements: Setting standards for the level of explainability required for different types of clinical algorithms, acknowledging that “black box” models pose unique challenges.
• Interoperability and Integration Audits: Verifying that AI models integrate smoothly and securely within existing health IT infrastructure, adhering to standards like HIPAA and HITRUST. HHS guidance on HIPAA compliance for health IT

These protocols would form the “how-to” guide for auditors, ensuring consistency and rigor.

Phase 3: Establishing a Federal Audit Body or Certification Program

To execute these audit protocols, two primary models emerge:

• Centralized Federal Audit Body: A dedicated agency or division, potentially within HHS, tasked with conducting or overseeing audits of high-risk clinical algorithms. This body would employ AI/ML experts, data scientists, and clinicians.
• Accredited Third-Party Certification Program: Using existing frameworks for medical device certification, the ONC could establish an accreditation program for third-party auditors. These accredited entities would conduct audits against the federal protocols, much like ISO 13485 certification for Quality Management Systems (QMS). ISO 13485 standard for medical devices This model could be particularly effective for scaling audit capacity.

Regardless of the model, the audit process must be transparent, with clear criteria for passing or failing, and mechanisms for remediation.

Phase 4: Continuous Monitoring and Post-Market Surveillance

Algorithmic auditing cannot be a one-time event. Clinical algorithms, by their nature, are dynamic. Therefore, the framework must include:

• Mandatory Post-Market Surveillance: Requiring developers to continuously monitor their algorithms for performance degradation, bias shifts, and real-world impact.
• Triggered Audits: Establishing criteria for initiating re-audits, such as significant changes to the model, evidence of algorithmic drift, or reports of adverse events related to AI use.
• Public Reporting of Audit Outcomes: Summaries of audit findings, while respecting proprietary information, should be made publicly available to enhance transparency and build trust.

A Concrete Roadmap for Federal Algorithmic Auditing

The establishment of objective audit standards for clinical algorithms is not merely a regulatory burden, but an investment in the future of healthcare AI. By synthesizing the foundational transparency requirements of the ONC HTI-1, championed by Micky Tripathi, with the strong risk management principles of the NIST AI RMF, federal agencies can construct a complete and actionable framework. This framework, characterized by standardized disclosures, objective audit protocols, a dedicated audit mechanism, and continuous surveillance, will provide the necessary guardrails for innovation, ensuring that healthcare AI is not only effective but also safe, fair, and accountable. This proactive approach will be critical as regulatory field like the EU AI Act continue to evolve, setting global precedents for AI governance. Methodology and Source Note: This analysis is based on a synthesis of federal IT standards, specifically drawing from the Office of the National Coordinator for Health Information Technology’s HTI-1 Transparency Requirements and the National Institute of Standards and Technology’s AI Risk Management Framework.